AtriCure Inc
ATRC36.660USD
+1.650+4.71%
終値 09/18, 16:00（ET）15分遅れの株価
1.82B時価総額
損失額直近12ヶ月PER
詳細情報 AtriCure Inc 企業名
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
企業情報
企業コードATRC
会社名AtriCure Inc
上場日Aug 05, 2005
最高経営責任者「CEO」Mr. Michael H. (Mike) Carrel, CPA
従業員数1300
証券種類Ordinary Share
決算期末Aug 05
本社所在地7555 Innovation Way
都市MASON
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号45040
電話番号15137554100
ウェブサイトhttps://www.atricure.com
企業コードATRC
上場日Aug 05, 2005
最高経営責任者「CEO」Mr. Michael H. (Mike) Carrel, CPA
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
708.94K
-1.39%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
83.96K
-3.45%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
-6.78%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+32.18%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+41.20%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
708.94K
-1.39%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
83.96K
-3.45%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-3.36%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Appendage Management-United states
42.09M
34.05%
Open Ablation - United states
33.31M
26.94%
Pain management
17.27M
13.97%
Appendage management -International
9.67M
7.83%
Open ablation -International
8.99M
7.28%
他の
12.28M
9.94%
地域別USD
会社名
収益
比率
United States
101.15M
81.82%
Europe
14.20M
11.49%
Asia
6.78M
5.49%
Other international
1.49M
1.20%
事業別
地域別
事業別USD
会社名
収益
比率
Appendage Management-United states
42.09M
34.05%
Open Ablation - United states
33.31M
26.94%
Pain management
17.27M
13.97%
Appendage management -International
9.67M
7.83%
Open ablation -International
8.99M
7.28%
他の
12.28M
9.94%
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.85%
Wellington Management Company, LLP
7.99%
AllianceBernstein L.P.
7.19%
BlackRock Institutional Trust Company, N.A.
6.94%
Hood River Capital Management LLC
6.16%
他の
61.88%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.85%
Wellington Management Company, LLP
7.99%
AllianceBernstein L.P.
7.19%
BlackRock Institutional Trust Company, N.A.
6.94%
Hood River Capital Management LLC
6.16%
他の
61.88%
種類
株主統計
比率
Investment Advisor
52.33%
Investment Advisor/Hedge Fund
39.16%
Hedge Fund
5.88%
Individual Investor
3.50%
Research Firm
1.63%
Pension Fund
0.81%
Bank and Trust
0.65%
Family Office
0.07%
Venture Capital
0.04%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
533
52.65M
105.93%
-5.83M
2025Q1
544
53.44M
107.95%
-4.07M
2024Q4
526
50.00M
102.31%
-11.07M
2024Q3
522
53.78M
110.47%
-8.64M
2024Q2
511
54.11M
111.85%
-4.03M
2024Q1
517
53.02M
109.65%
-1.47M
2023Q4
515
50.20M
105.93%
-1.70M
2023Q3
504
48.87M
103.22%
-3.82M
2023Q2
499
48.88M
103.48%
-3.46M
2023Q1
503
48.62M
102.63%
-1.48M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
4.70M
9.5%
+61.17K
+1.32%
Mar 31, 2025
AllianceBernstein L.P.
3.68M
7.43%
-158.60K
-4.14%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.57M
7.21%
-92.41K
-2.52%
Mar 31, 2025
Hood River Capital Management LLC
3.00M
6.06%
+75.48K
+2.58%
Mar 31, 2025
Macquarie Investment Management
2.44M
4.92%
+61.60K
+2.59%
Mar 31, 2025
Champlain Investment Partners, LLC
2.14M
4.32%
-390.65K
-15.45%
Mar 31, 2025
State Street Global Advisors (US)
1.28M
2.58%
-68.53K
-5.09%
Mar 31, 2025
Neuberger Berman, LLC
1.19M
2.4%
+246.88K
+26.29%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.17M
2.36%
+16.11K
+1.40%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
